Concepedia
Statistics
Publications
4
Citations
316
H-Index
Active since
2019
Affiliations
Ben-Gurion University of the Negev(Current)
Deutsches Konsortium für Translationale Krebsforschung
German Cancer Research Center
Heidelberg University
Heinrich Heine University Düsseldorf
Gal Mazor is an author at Ben-Gurion University of the Negev specializing in oncology, gene expression, and medicine.
Publications per year
2019–2023
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
Gal Mazor, Liron Levin, Daniel Picard et al. · Cell Death and Disease · 2019 · 190 citations · Full text
Life Sciences, Cancer Biology, Cell Biology +17
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Julian Musa, Florencia Cidre‐Aranaz, Marie-Ming Aynaud et al. · Nature Communications · 2019 · 72 citations · Full text
Medicine, Genetics, Oncology +17
The long noncoding RNA <i>TP73‐AS1</i> promotes tumorigenicity of medulloblastoma cells
Mor Varon, Tal Levy, Gal Mazor et al. · International Journal of Cancer · 2019 · 36 citations
Life Sciences, Molecular Biology, Oncology +17
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
Keren Rouvinov, Gal Mazor, Ella Kozlener et al. · Journal of Personalized Medicine · 2023 · 18 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
1–4 of 4